www.heart.org·3 min read·hard
Can GLP-1 medications improve health in people with Type 2 diabetes and PAD?
✦AI Summary
New research published in the Journal of the American Heart Association suggests that GLP-1 receptor agonists can reduce mortality and amputation risks in Type 2 diabetes patients with peripheral artery disease. The study indicates these drugs may be more effective than metformin for this specific patient group.
Why it matters
This finding could change clinical treatment protocols for patients suffering from both diabetes and severe circulatory issues.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, July 1, 2026
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
Reports on peer-reviewed medical research findings objectively.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in